The THC study titled “Risk of Dementia in Individuals With Emergency Department Visits or Hospitalizations Due to Cannabis” (PMID: 40227745) was published online ahead of print in JAMA Neurology on April 14, 2025. It investigates whether individuals who had emergency department (ED) visits or hospitalizations related to cannabis use are at an increased risk of developing dementia. (Charles Keckler – X, Risk of Dementia in Individuals With Emergency Department Visits …)
Key Findings
This large, population-based retrospective cohort study—published in JAMA Neurology (2025)—examined whether individuals with emergency department (ED) visits or hospitalizations due to cannabis use are at increased risk of developing dementia. Using Ontario health administrative data from over 6 million adults aged 45 to 105 years (with no prior dementia diagnosis), the study tracked outcomes for up to 14 years. It found that those with cannabis-related acute care had a significantly higher risk of being diagnosed with dementia within five years—about 1.7 times higher than the general population and 1.2 times higher than those with other types of acute care. Interestingly, their dementia risk was lower than that of individuals with alcohol-related acute care. The study highlights a rapid rise in cannabis-related acute care visits, especially among older adults, and underscores a potential link between such incidents and long-term cognitive decline.
Study Quality and Design
As for quality, this was a well-designed observational study with a very large sample size and robust statistical adjustments for potential confounders (e.g., age, comorbidities, demographics). However, like all retrospective studies, it can demonstrate association, not causation. Confounding by indication (e.g., underlying psychiatric or neurological conditions prompting cannabis use or ED visits) and limitations in ICD coding accuracy remain concerns. Despite this, the study’s methodology, scope, and findings contribute meaningfully to the emerging literature on cannabis and cognitive outcomes, and its publication in a high-impact journal adds credibility. Overall, it was a strong study, especially for hypothesis generation and public health awareness. For more detailed information, you can access the full study here: PubMed PMID: 40227745.
Treatment
Cannabis Use Disorder is a real addiction and a real threat. If you or a loved one would like more information regarding evidence-based Treatment, please call or text us today at (772) 584-3083.
